These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23687794)

  • 41. Treatment of invasive bladder cancer (lymph node negative, metastases negative).
    Chisholm GD
    Prog Clin Biol Res; 1989; 303():559-61. PubMed ID: 2780661
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ⅲ.The History of Developing Anticancer Drug for Urothelial Carcinoma and Future Issues].
    Kojima T
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):41-45. PubMed ID: 33468721
    [No Abstract]   [Full Text] [Related]  

  • 43. Interview with Dr Richard Sylvester: transition cell carcinoma of the bladder. Interview by Christine McKillop.
    Sylvester R
    Eur Urol; 2007 Jun; 51(6):1748-50. PubMed ID: 17374436
    [No Abstract]   [Full Text] [Related]  

  • 44. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 45. Laser treatment of bladder cancer.
    Smith JA
    Semin Urol; 1985 Feb; 3(1):2-9. PubMed ID: 3159062
    [No Abstract]   [Full Text] [Related]  

  • 46. A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
    Blackledge G; Roberts JT; Kaye S; Taylor R; Williams J; de Stavola B; Uscinska B
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):391-2. PubMed ID: 2702992
    [No Abstract]   [Full Text] [Related]  

  • 47. Chemotherapy of bladder cancer: current progress.
    Murphy GP
    N Y State J Med; 1977 Oct; 77(12):1889-95. PubMed ID: 270015
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of superficial transitional cell carcinoma of the bladder].
    Nissenkorn J
    Harefuah; 1982 May; 102(10):436-8. PubMed ID: 7160676
    [No Abstract]   [Full Text] [Related]  

  • 49. Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.
    Tickoo SK; Milowsky MI; Dhar N; Dudas ME; Gallagher DJ; Al-Ahmadie H; Gopalan A; Fine SW; Ishill N; Bajorin DF; Reuter VE
    BJU Int; 2011 Mar; 107(5):844-849. PubMed ID: 20707797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypothalamitis and severe hypothalamic dysfunction associated with anti-programmed cell death ligand 1 antibody treatment.
    Tshuma N; Glynn N; Evanson J; Powles T; Drake WM
    Eur J Cancer; 2018 Nov; 104():247-249. PubMed ID: 30377030
    [No Abstract]   [Full Text] [Related]  

  • 51. Urothelial carcinoma with squamous differentiation: response to chemotherapy and radiation.
    Clark PE
    Urol Oncol; 2015 Oct; 33(10):434-6. PubMed ID: 26278365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Thermo-Sensitive Hydrogel Therapy for Low-Grade Upper Tract Urothelial Carcinoma.
    Patel SR; Lerner SP
    J Urol; 2021 Aug; 206(2):191-193. PubMed ID: 33787301
    [No Abstract]   [Full Text] [Related]  

  • 53. Intravesical and systemic chemotherapy of murine bladder cancer.
    Soloway MS
    Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041
    [No Abstract]   [Full Text] [Related]  

  • 54. Urothelial cancers: using biology to improve outcomes.
    Pezaro C; Liew MS; Davis ID
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):87-98. PubMed ID: 22149435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder.
    Mazzola CR; Siddiqui KM; Billia M; Chin J
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1553-62. PubMed ID: 25284004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of chemotherapeutic agents on bladder cancer: a new animal model.
    Soloway MS; deKernion JB; Rose D; Persky L
    Surg Forum; 1973; 24():542-4. PubMed ID: 4806091
    [No Abstract]   [Full Text] [Related]  

  • 58. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
    Pectasides D; Pectasides M; Economopoulos T
    Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chemotherapy for urothelial cancer of the bladder--update 2012].
    Niegisch G; Lorch A; Albers P
    Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Implementation of clinical urological studies and therapy trials using GCP (good clinical practice) guidelines].
    Jocham D
    Urologe A; 1994 Nov; 33(6):532-5. PubMed ID: 7817452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.